Thomas Heineman

Technik-/Wissenschafts-/F&E-Leiter bei ONCOLYTICS BIOTECH INC.

Vermögen: 552 334 $ am 31.05.2024

Health Technology

Consumer Services

Aktive Positionen von Thomas Heineman

Unternehmen	Position	Beginn	Ende
ONCOLYTICS BIOTECH INC.	Technik-/Wissenschafts-/F&E-Leiter	01.08.2020	-

Unternehmen	Position	Beginn	Ende
Denovo Biopharma LLC Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA.	Corporate Officer/Principal	01.01.2020	01.07.2020
GENOCEA BIOSCIENCES, INC.	Corporate Officer/Principal	01.08.2016	01.01.2020
HALOZYME THERAPEUTICS, INC.	Technik-/Wissenschafts-/F&E-Leiter	01.02.2018	01.01.2020
HALOZYME THERAPEUTICS, INC.	Corporate Officer/Principal	01.02.2018	01.01.2020
GSK PLC	Technik-/Wissenschafts-/F&E-Leiter	01.01.2006	01.08.2016
Saint Louis University School of Medicine	Corporate Officer/Principal	-	-

The University of Chicago

Doctorate Degree

International

Operativ

Corporate Officer/Principal	4
Chief Tech/Sci/R&D Officer	3
Doctorate Degree	1

Sektoral

Health Technology	6
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	4
HALOZYME THERAPEUTICS, INC.	Health Technology
ONCOLYTICS BIOTECH INC.	Health Technology
GENOCEA BIOSCIENCES, INC.	Health Technology
GSK PLC	Health Technology

Private Unternehmen	1
Denovo Biopharma LLC Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA.	Health Technology